№ files_lp_4_process_3_097547
File format: docx
Character count: 4619
File size: 27 KB
This document provides guidelines for collecting data on medications taken prior to and during a study, to assess potential interactions and eligibility.
Note:
Year
Document Type:
CRF (Case Report Form)
Target Audience:
Research teams, Clinical Study Personnel
Period of Use:
Ongoing during the study
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Subject:
Concomitant medications tracking
Document Type:
Template
Organization / Institution:
NIMH
Target Audience:
Principal Investigators, study team members
Year:
2019
Institution:
Utah State University
Location:
Logan, Utah
Author:
Linda K. Todd
Degree:
Doctor of Philosophy; Master of Science
Field of Study:
Psychology
Document Type:
Dissertation and Thesis Submission Pages
Approving Authority:
Richard S. Inouye, Ph.D., Vice Provost for Graduate Studies
Academic Level:
Graduate
Subject Focus:
Diagnosis of Anorexia Nervosa, Bulimia Nervosa, and Concomitant Conditions
Related Conditions:
Anorexia nervosa; Bulimia nervosa
Year:
2019
Region / City:
Massachusetts, USA
Subject:
Pharmaceutical policy updates
Document Type:
Update bulletin
Organization:
MassHealth
Effective Dates:
November 8, 2019 – November 25, 2019
Medications Added:
Zolgensma, Abilify Mycite, Adhansia XR, Apadaz, Evekeo ODT, Inbrija, Jornay PM, Katerzia, Krintafel, Minolira, Polivy, Prograf, Qmiiz, Rozlytrek, Sunosi, Triluron, Vyndamax
Changes in Prior Authorization:
Benzodiazepines with opioids, Proton pump inhibitors, Influenza treatments
Brand Name Preferred Updates:
Dexilant added, Voltaren Gel removed
Abbreviations:
PA – Prior Authorization, BP – Brand Preferred, CO – Carve-Out, PD – Preferred Drug
Target Audience:
Healthcare providers prescribing MassHealth-covered medications
Implementation Date:
November 25, 2019
Reference Website:
www.mass.gov/druglist
Updates Type:
Additions, deletions, PA changes, policy clarifications
Clinical Focus:
Concomitant opioid and benzodiazepine usage and safe prescribing requirements
Regulatory Context:
FDA “A”-rated generic equivalents and MassHealth formulary requirements
Healthcare Impact:
Affects MassHealth members outside MCO plans
Year:
2023
Region / city:
International
Topic:
Cardiovascular research
Document type:
Scientific appendix
Organization:
REDWOOD-HCM, SEQUOIA-HCM, FOREST-HCM Investigators
Author:
Ahmad Masri, MD, MS; Martin S. Maron; Theodore P. Abraham, MD; Michael E. Nassif, MD; Roberto Barriales-Villa, MD; Ozlem Bilen, MD; Caroline J. Coats, MD, PhD; Perry Elliott, MBBS, MD; Pablo Garcia-Pavia, MD PhD; Daniele Massera, MD; Iacopo Olivotto, MD; Artur Oreziak, MD, PhD; Anjali Tiku Owens, MD; Sara Saberi, MD, MS; Scott D. Solomon, MD; Albree Tower-Rader, MD; Stephen B. Heitner, MD; Daniel L. Jacoby, MD; Chiara Melloni, MD, MS; Jenny Wei, PhD; MD; Mark V. Sherrid, MD
Target audience:
Cardiologists, researchers in cardiovascular medicine
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
1997
Region / City:
United States
Topic:
Inpatient medication management
Document Type:
Manual
Organization / Institution:
Department of Veterans Affairs
Author:
Not specified
Target Audience:
Healthcare professionals in the Veterans Affairs system
Effective Period:
Ongoing updates
Approval Date:
December 1997
Revision Date:
August 2025
Year:
2005
Region / City:
United States
Topic:
Health Systems Design and Development
Document Type:
Release Notes
Organization / Institution:
Department of Veterans Affairs
Author:
Department of Veterans Affairs
Target Audience:
Health care professionals using CPRS
Period of Validity:
April 2006
Approval Date:
1/31/2005
Modification Date:
5/18/2005
Year:
2018
Region / City:
Rwanda
Theme:
Medication Management
Document Type:
Policy
Organization / Institution:
Ministry of Health, Rwanda
Author:
Chief Pharmacist
Target Audience:
Clinical Staff
Period of Validity:
Not specified
Approval Date:
August 2018
Revision Date:
July 2020
Purpose:
To ensure safe medication practices across clinical areas
Year:
2015
Region / City:
United Kingdom
Subject:
Medication management in care homes
Document Type:
Guidance / Good Practice Document
Organization:
Chiltern and Aylesbury Vale CCG
Authors:
Unoma Okoli, Seema Gadhia
Intended Audience:
Care home staff responsible for administering PRN medications
Approval Date:
21 May 2015
Review Date:
May 2018
References:
NICE SC1: 2014; CQC Pharmacy Tip: October 2008; British National Formulary April 2015; CCG Care Homes Guidance
Includes Appendices:
Yes (PRN template and example)
Year:
2010
Region / city:
Glendale, CO
Subject:
Pharmaceutical services, Bubble packaging
Document Type:
Sources Sought Notice
Agency:
Department of Veterans Affairs
Author:
Robert Woolfolk II
Target audience:
Service Disabled Veteran Owned Small Businesses, Veteran Owned Small Businesses, 8(a), HUBZone, and other Small Businesses
Period of validity:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Description:
The document outlines the market research announcement for a contractor to provide bubble packaging of medications for the Veterans Health Administration Salt Lake City Health Care System (VHASLCHCS).
Year:
2025
Region / city:
United States
Topic:
Healthcare, Medication Management, Software Upgrade
Document Type:
Release Notes
Organization / Institution:
Department of Veterans Affairs, Office of Information and Technology (OIT)
Author:
Department of Veterans Affairs
Target Audience:
Users and administrators of FDB Fwk Upgrade v4.5
Effective Period:
May 2025
Approval Date:
May 2025
Modification Date:
None listed
Note:
Year
Topic:
Health care, medication administration
Document type:
Agreement
Jurisdiction:
Commonwealth of Massachusetts
Regulatory reference:
105 CMR 430.160
Document type:
Acknowledgement form
Subject area:
Camp health services and medication administration
Role defined:
Health Care Consultant
Medical license types referenced:
Physician, Physician Assistant, Nurse Practitioner
Authorized activity:
Administration of prescription medications to campers
Conditions of administration:
Parental or guardian written permission required; medications delivered to and maintained by the camp
Oversight:
Professional oversight by the Health Care Consultant
Signatories:
Health Care Consultant
Applicable setting:
Camp
Source type:
Administrative compliance record
Year:
2007
Region / City:
United States
Topic:
Healthcare Software Updates
Document Type:
Release Notes
Organization / Institution:
Department of Veterans Affairs
Author:
VistA Health Systems Design & Development
Target Audience:
Healthcare professionals using VistA system
Effective Period:
2007
Approval Date:
03/29/2007
Modification Date:
October 2007
Year:
1997
Region / City:
United States
Subject:
Healthcare, Medication Management
Document Type:
User Manual
Organization:
Department of Veterans Affairs
Author:
Not specified
Target Audience:
Healthcare professionals in the Veterans Affairs system
Period of validity:
Not specified
Approval Date:
December 1997
Date of Changes:
May 2025
Revision History:
Yes
Context:
This document is a user manual detailing the management and updates of inpatient medication systems for healthcare professionals.
Note:
Date
December 30, 2025, at 02:
00 PM (Kabul, Afghanistan Time)
Year:
2021
Region / City:
Rockville, MD
Topic:
340B Drug Pricing Program
Document Type:
Guidance
Organization / Institution:
Health Resources and Services Administration (HRSA)
Author:
Apexus
Target Audience:
340B stakeholders, covered entities, health departments
Effective Period:
Ongoing
Approval Date:
2021
Date of Changes:
N/A
Year:
2019
Region / City:
Queensland
Topic:
Medications Management
Document Type:
Plan
Organization / Institution:
Department of Education
Author:
Not specified
Target Audience:
Staff members responsible for managing and administering medications in schools
Period of Validity:
5 years
Approval Date:
Not specified
Date of Last Review:
Not specified
Date of Changes:
Not specified
References:
Administration of medications in schools procedure, Queensland Health Departmental Standard
Description:
Plan for managing risks related to the purchase, possession, administration, and disposal of medications, including emergency medications in schools.
Year:
N/A
Region / City:
N/A
Topic:
Medication Authorization Process
Document Type:
Procedure
Organization / Institution:
N/A
Author:
N/A
Target Audience:
Healthcare Providers
Period of Action:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Context:
Detailed guide on the prior authorization process for anti-obesity medications (AOMs), including steps for verification, documentation, and follow-up actions for insurance approval.
Year:
2026
Region / City:
United States
Topic:
Federal procurement and contract management
Document Type:
Policy/Guidance
Agency / Institution:
GSA (General Services Administration)
Author:
GSA
Target Audience:
Contractors, Government Agencies
Period of Validity:
Ongoing
Approval Date:
N/A
Modification Date:
N/A